Researchers based at Brigham and Women's Hospital and Harvard Medical School conducted a randomised, double-blind study from 1997 to 2011 of 14,641 US male doctors aged 50 and older.
Half took a common daily multivitamin, as well as vitamin C, vitamin E and beta carotene supplements. The other half took a placebo.
The researchers followed the participants to identify how many participants in each group developed new cases of two common eye diseases: cataract, which is a clouding of the eye's lens, and age-related macular degeneration (AMD), the deterioration of the eye's macula that is responsible for the ability to see fine details clearly.
This risk was even lower, at 13 per cent, for nuclear cataract, which occurs at the centre of the lens and is the most common variety of cataract associated with the ageing process.
"If multivitamins really do reduce the risk of cataract, even by a modest 10 per cent, this rather small reduction would nonetheless have a large public health impact," said William Christen, the study's lead author and researcher from Harvard Medical School.
"This finding of more cases of AMD in the multivitamin group than in the placebo group, although not statistically significant, does raise some concerns," said Christen.
"Clearly, this finding needs to be examined further in other trials of multivitamin supplements in both men and women," Christen added.
The study was published in Ophthalmology, the journal of the American Academy of Ophthalmology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
